Resultats de la cerca - Stephan Stilgenbauer

Response to Comment by Jonathan Weiss et al. per Eugen Tausch, Stephan Stilgenbauer

Obtenir text complet

BIRC3 mutations in chronic lymphocytic leukemia – uncommon and unfavorable per Eugen Tausch, Stephan Stilgenbauer

Obtenir text complet

Biological diversity and risk-adapted treatment of chronic lymphocytic leukemia per Thorsten Zenz, Daniel Mertens, Stephan Stilgenbauer

Obtenir text complet

Chronic lymphocytic leukemia – genomics lead the way per Daniel Mertens, Lars Bullinger, Stephan Stilgenbauer

Obtenir text complet

First-line treatment for CLL in the era of targeted therapy per Matthew S. Davids, Stephan Stilgenbauer, Constantine S. Tam

Obtenir text complet

From Biology to Therapy: The CLL Success Story per Deyan Y. Yosifov, Christine Wolf, Stephan Stilgenbauer, Daniel Mertens

Obtenir text complet

repDilPCR: a tool for automated analysis of qPCR assays by the dilution-replicate method per Deyan Yordanov Yosifov, Michaela Reichenzeller, Stephan Stilgenbauer, Daniel Mertens

Obtenir text complet

Genotyping from targeted NGS data based on a small set of SNPs correctly matches patient samples per Deyan Yordanov Yosifov, Christof Schneider, Stephan Stilgenbauer, Daniel Mertens, Eugen Tausch

Obtenir text complet

Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2 per Angela Schulz, Grischa Toedt, Thorsten Zenz, Stephan Stilgenbauer, Peter Lichter, Martina Seiffert

Obtenir text complet

The MDM2 –309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemia per Thorsten Zenz, Sonja Häbe, Axel Benner, Dirk Kienle, Hartmut Döhner, Stephan Stilgenbauer

Obtenir text complet

TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics per Elias Campo, Florence Cymbalista, Paolo Ghia, Ulrich Jäger, Sarka Pospisilova, Richard Rosenquist, Anna Schuh, Stephan Stilgenbauer

Obtenir text complet

Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice per Bola S. Hanna, Haniyeh Yazdanparast, Yasmin Demerdash, Philipp M. Roessner, Ralph Schulz, Peter Lichter, Stephan Stilgenbauer, Martina Seiffert

Obtenir text complet

Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic Leukemia per Sebastian Faehling, Mariana Coelho, Alessia Floerchinger, Christof Schneider, Stephan Stilgenbauer, Peter Lichter, Martina Seiffert, Philipp M. Roessner

Obtenir text complet

TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q per Angela Garding, Nupur Bhattacharya, Sarah Haebe, Frederike Müller, Dieter Weichenhan, Irina Idler, Katja Ickstadt, Stephan Stilgenbauer, Daniel Mertens

Obtenir text complet

Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia per Eugen Tausch, William Close, Anna Dolnik, Johannes Bloehdorn, Brenda Chyla, Lars Bullinger, Hartmut Döhner, Daniel Mertens, Stephan Stilgenbauer

Obtenir text complet

Overall survival outcomes with first‐line continuous ibrutinib and fixed‐duration ibrutinib‐venetoclax treatments in patients with chronic lymphocytic leukemia: Comparison with an... per Paolo Ghia, Loic Ysebaert, Ann Janssens, Stephan Stilgenbauer, Mohamed Fouad, Claudio A. Schioppa, José‐Ángel Hernández‐Rivas, Alessandra Tedeschi

Obtenir text complet

Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival per Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger, Axel Benner, Elke Leupolt, Dirk Winkler, Alexander Kröber, Dirk Kienle, Peter Lichter, Hartmut Döhner

Obtenir text complet

Corrigendum to “U-RT1 – A new model for Richter transformation” [Neoplasia Volume 23, Issue 1, January 2021, Pages 140-148] per Teresa Schmid, Julia Maier, Melanie Martin, Alpaslan Tasdogan, Eugen Tausch, Thomas F.E. Barth, Stephan Stilgenbauer, Johannes Bloehdorn, Peter Möller, Kevin Mellert

Obtenir text complet

Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling per Katharina Filarsky, Angela Garding, Natalia Becker, Christine Wolf, Manuela Zucknick, Rainer Claus, Dieter Weichenhan, Christoph Plass, Hartmut Döhner, Stephan Stilgenbauer, Peter Lichter, Daniel Mertens

Obtenir text complet

Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia per Raúl Córdoba, Stephan Stilgenbauer, Paolo Ghia, Alessandra Tedeschi, Lindsey Roeker, Myriam Rodriguez‐Couso, Stephen P. Mulligan, Samir Kanaan Nabhan, Jan Rynne, Teresa López‐Fernández

Obtenir text complet